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Most bovine estrous synchronization
protocols utilize progesterone plus estrogen
to control ovulation timing. A drug that
inhibits estrogen production (Letrozole)
may be an alternative, steroid-free synchronization method (not yet commercially
available). However, low estrogen can negatively affect the health of follicles/oocytes
and impact fertility. To determine its effects,
Letrozole was administered intramuscularly
while tracking follicle growth and circulating hormones. Letrozole response was
variable. Two of three cows experienced
delayed luteolysis/ovulation and extended
progesterone production. This preliminary
data indicates that Letrozole treatment
allows normal follicle progression but drug
response may vary and little is known about
effects on oocyte quality.

methods using pharmaceuticals that are
not hormone-based but instead control
the synthesis of hormones in the treated
animal. Having a lower concentration of
estrogen within the bloodstream prevents the sequence of events that result in
ovulation (i.e. loss of the corpus luteum
due to luteolysis, decreased circulating
progesterone, and a surge in Luteinizing
Hormone). Thus, some researchers have
proposed Letrozole, an aromatase inhibitor that decreases estrogen production,
as a steroid-free estrous synchronization
method. These researchers have had success in controlling the timing of ovulation.
However, having lower concentrations
of estrogens inside the dominant ovarian follicle is associated with decreased
oocyte quality and fertility. Plus, delaying
ovulation with a method that changes
gonadotropin pulsatility (as with altering
circulating estrogen) can potentially cause
the development of a persistent follicle
and reduced quality of the oocyte within
the follicle. To determine whether Letrozole treatment promotes persistent follicle
formation, a pilot trial to test its effects
on follicle development and circulating
hormone concentrations was performed
using a small group of beef cows.

Introduction

Procedure

The benefits of reliable estrous synchronization for timed artificial insemination are well known. Since estrous is
controlled primarily by the cyclical nature
of steroid hormones, most synchronization protocols administer steroids such
as progesterone and estrogen to prevent
ovulation until a desired time. However,
there is a public desire to avoid hormone
treatments in beef cattle including legal
prohibition of estrogen use in some
countries. For this reason, some researchers seek to devise new synchronization

All procedures were approved by the
Animal Care and Use Committee at the
University of Nebraska-Lincoln. Six non-
lactating, composite beef cows (25% MARC
III [¼ Angus, ¼ Hereford, ¼ Pinzgauer, ¼
Red Poll] and 75% Red Angus) ages 2-4 yr
old from the beef physiology herd at the
Eastern Nebraska Research and Extension
Center (ENREC) were initially synchronized with two injections (25 mg/cow; i.m.;
12 h apart) of prostaglandin F2α (PGF2α)
following by a second pair of PGF2α injections 14 d later. Transrectal ultrasound with
an Aloka UST-5541-7.5 probe was conducted every other day for three weeks then daily for 50 d total, and the follicle and corpus

Summary and Implications
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luteum dimensions were measured along
the longest axis and the perpendicular axis
(the average of those two dimensions is
presented). Ovulation was determined by
the absence of the preovulatory follicle.
Estrus was detected using Estrotect™ Heat
Detector patches on the tail head. Blood
samples were collected every other day for
the first week then daily, and circulating
progesterone was measured with radioimmunoassays performed in duplicate. For
this experiment, Day 1 of the reproductive
cycle was defined as the day of ovulation
detection after the second set of PGF2α injections. Treatment (250µg/kg Letrozole in
8-10 mL of a 1:5 mixture of benzyl alcohol
and sesame oil) or control injections (8 mL
of 1:5 benzyl alcohol/sesame oil) began on
Day 10 of the cycle.

Results
When using Letrozole to inhibit aromatase activity, an important consideration
is the success and degree of circulating
estrogen suppression. The purpose of
the drug is not to completely prevent all
estrogen production but instead to prevent
or delay the peak in estrogen production
that occurs prior to ovulation. In the three
treated cows, there was still a moderate
amount of circulating estrogen during and
after the treatment period. However, the
peak of estrogen from the dominant follicle
that must occur before ovulation occurs
was delayed in two of the three treated cows
(Figure 1, Treated Cows 1 and 2). This suggests the possibility that the processing of
Letrozole by the liver may vary from animal
to animal, thus making the effectiveness of
the drug inconsistent.
The effects of Letrozole on the reproductive cycle were also variable, with the
successful suppression of the estrogen peak
corresponding with a delay in ovulation. Of
the three control cows that received vehicle
injections only, two of the cows had a two-
follicular-wave cycle and one of them had
a three-wave cycle (Figure 2). The intervals
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Figure 1. Letrozole aromatase inhibition delays the circulating estrogen peak that occurs prior to estrus and ovulation. The top three graphs depict the daily estradiol concentration (ng/mL) of the Control cows, and the bottom three graphs depict estradiol of the Letrozole-treated cows. The day of estrus is shown with a
light-gray bar, and the six days of injections are depicted with dark-gray bars. Treated Cows 1 and 2 had delays in the pre-estrus estradiol peaks.

between ovulation for the control cows
were 20 d, 25 d, and 26 d. Comparatively,
one Letrozole-treated cow had a two-wave
cycle with no delay in ovulation (Cow 3, 21
d), while the other two treated cows had
three-wave cycles with ovulation intervals
of 27 (Cow 2) and >32 (Cow 1, did not
ovulate during the experimental period)
(Figure 2). The ovulation delays were accompanied by an extended period of peak
progesterone production and a delay in
corpus luteum lysis. This suggests that the
way in which Letrozole delays ovulation is
by preventing/delaying luteolysis.

Conclusions
Letrozole estrous synchronization is
feasible because the decreased circulating estrogen delays luteolysis, possibly
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by inhibiting the animal’s own PGF2α
production. Commercial PGF2α can then
be administered to trigger luteolysis and
the subsequent ovulation event. The results
of this study indicate that there is little risk
to the developmental progression of the
follicle from the Letrozole treatment, since
the dominant follicle during the treatment
period will either ovulate or undergo atresia
rather than becoming a persistent or cystic
follicle. However, a follicle that ovulates after being exposed to Letrozole may not contain a high quality oocyte. More research is
needed to confirm that Letrozole does not
adversely affect the health or capacity of the
oocyte to be fertilized before it is incorporated into synchronization protocols.
A controlled-release version of this drug
(similar to a CIDR) has been patented, but
this is not yet commercially available for
timed AI purposes. This drug should not be

recommended to producers until further
research assures the health and quality of
the oocyte within the follicle and until larger studies show that the animal-to-animal
variability is acceptable.
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Figure 2. Letrozole-treated cows experience variable delayed ovulation and extended peak progesterone production. For the follicle diameter graphs, each
point represents an individual follicle measurement and the tracked follicles are connected by lines. The top three graphs depict the ultrasound-tracked follicle
measurements and ovulation (shown as a star-shaped icon) of the Control Cows, while the three graphs immediately below are the ultrasound-tracked corpus
luteum diameter (primary vertical axis) and the circulating progesterone (ng/mL; secondary vertical axis) of the Control Cows. The six graphs at the bottom
show the follicle measurements, corpus luteum measurements, and circulating progesterone for the Letrozole-treated cows. The day of estrus is shown with
a light-gray bar, and the six days of injections are depicted with dark-gray bars. Treated Cows 1 and 2 had delayed luteolysis and extended peak progesterone
concentrations.
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